We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

75 hedge funds and large institutions have $27.9M invested in ENZON PHARMACEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 21

5% less funds holding

Funds holding: 79 → 75 (-4)

18% less capital invested

Capital invested by funds: $34.2M → $27.9M (-$6.32M)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

85% less call options, than puts

Call options by funds: $3K | Put options by funds: $20K

Holders
75
Holders Change
-4
Holders Change %
-5.06%
% of All Funds
2.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
22
Reduced
21
Closed
10
Calls
$3K
Puts
$20K
Net Calls
-$17K
Net Calls Change
-$19K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$450K
2
BIT
BlackRock Institutional Trust
California
+$366K
3
California Public Employees Retirement System
California Public Employees Retirement System
California
+$348K
4
MERSOM
Municipal Employees' Retirement System of Michigan
Michigan
+$309K
5
Renaissance Technologies
Renaissance Technologies
New York
+$213K

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$5.03M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$121K
3
WMSA
Weiss Multi-Strategy Advisers
New York
-$78K
4
Goldman Sachs
Goldman Sachs
New York
-$55.8K
5
Northern Trust
Northern Trust
Illinois
-$49.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$204K -$23.8K -23,088 -10%
CL
27
CSS LLC
Illinois
$203K – – –
SIM
28
Spark Investment Management
New York
$195K +$84K +81,300 +74%
Two Sigma Investments
29
Two Sigma Investments
New York
$173K -$21.8K -21,075 -11%
TCIM
30
TIAA CREF Investment Management
New York
$172K – – –
Two Sigma Advisers
31
Two Sigma Advisers
New York
$165K +$41.3K +40,023 +33%
PAM
32
Panagora Asset Management
Massachusetts
$156K – – –
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$134K – – –
BIM
34
BlackRock Investment Management
Delaware
$133K -$2.13K -2,058 -2%
BIM
35
Bogle Investment Management
Massachusetts
$132K -$413 -400 -0.3%
AG
36
Algert Global
California
$129K – – –
GC
37
Globeflex Capital
California
$103K -$1.15K -1,116 -1%
FQ
38
First Quadrant
California
$84K +$36.5K +35,300 +76%
Charles Schwab
39
Charles Schwab
California
$82K – – –
Los Angeles Capital Management
40
Los Angeles Capital Management
California
$80K -$8.9K -8,620 -10%
BJ
41
BlackRock Japan
Japan
$76K – – –
Barclays
42
Barclays
United Kingdom
$71K +$48.7K +47,187 +192%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$70K – – –
State Board of Administration of Florida Retirement System
44
State Board of Administration of Florida Retirement System
Florida
$60K – – –
AllianceBernstein
45
AllianceBernstein
Tennessee
$58K -$5.99K -5,800 -9%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$57K -$1.9K -1,840 -3%
TA
47
Teachers Advisors
New York
$52K – – –
PPA
48
Parametric Portfolio Associates
Washington
$49K -$8.87K -8,589 -15%
CS
49
Credit Suisse
Switzerland
$42K -$6.96K -6,740 -14%
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$40K – – –
1
2
3 4

ENZN Hedge Fund Activity: Q1 2014 in Review

75 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q1 2014, worth a combined $27.9M — down 18% from $34.2M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ENZN and 7 opened new positions — a net loss of 3 holders — while 21 trimmed existing stakes and 22 added.

The largest buyer was Citadel Advisors, adding an estimated $450K. The largest seller was Baupost Group, exiting entirely with an estimated $5.03M sold.

  • 75 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q1 2014, down from 79 in Q4 2013.
  • Funds reported $27.9M of ENZON PHARMACEUTICALS INC stock for Q1 2014, down 18% quarter-over-quarter.
  • 7 funds opened new ENZON PHARMACEUTICALS INC positions in Q1 2014 and 10 closed out, a net change of -3 holders.
  • The largest ENZON PHARMACEUTICALS INC buyer in Q1 2014 was Citadel Advisors, an estimated $450K added.
  • The largest ENZON PHARMACEUTICALS INC seller in Q1 2014 was Baupost Group, an estimated $5.03M sold.

Based on aggregated 13F filings for Q1 2014.